{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:13:52Z","timestamp":1775902432909,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartfailure.theclinics.com","mdconsult.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.hfc.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T08:50:29Z","timestamp":1403859029000},"page":"481-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Comorbidities and Differential Diagnosis in Heart Failure with Preserved Ejection Fraction"],"prefix":"10.1016","volume":"10","author":[{"given":"Ross T.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9280","key":"10.1016\/j.hfc.2014.04.009_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(01)05620-3","article-title":"Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study","volume":"358","author":"Davies","year":"2001","journal-title":"Lancet"},{"issue":"9081","key":"10.1016\/j.hfc.2014.04.009_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(97)03033-X","article-title":"Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population","volume":"350","author":"McDonagh","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.hfc.2014.04.009_bib4","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hfc.2014.04.009_bib5","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.102.10.1126","article-title":"Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995","volume":"102","author":"MacIntyre","year":"2000","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.hfc.2014.04.009_bib6","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1053\/euhj.2000.2533","article-title":"The prognosis of heart failure in the general population: The Rotterdam Study","volume":"22","author":"Mosterd","year":"2001","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2014.04.009_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hfc.2014.04.009_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.hfc.2014.04.009_bib9","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","article-title":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis","volume":"33","author":"Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)","year":"2012","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.hfc.2014.04.009_bib10","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.hfc.2014.04.009_bib11","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.296.18.2209","article-title":"Systolic and diastolic heart failure in the community","volume":"296","author":"Bursi","year":"2006","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.hfc.2014.04.009_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurjhf\/hfr170","article-title":"Ten-year prognosis of heart failure in the community: follow-up data from the Echocardiographic Heart of England Screening (ECHOES) study","volume":"14","author":"Taylor","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.hfc.2014.04.009_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-137-8-200210150-00006","article-title":"Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study","volume":"137","author":"Gottdiener","year":"2002","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.hfc.2014.04.009_bib15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0002-9149(00)01165-6","article-title":"Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study","volume":"86","author":"Devereux","year":"2000","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.hfc.2014.04.009_bib16","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0195-668X(02)00845-X","article-title":"Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function","volume":"24","author":"Gustafsson","year":"2003","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.hfc.2014.04.009_bib17","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.hfc.2014.04.009_bib18","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2014.04.009_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2014.04.009_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehm554","article-title":"Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study","volume":"29","author":"Tribouilloy","year":"2008","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hfc.2014.04.009_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCA.0b013e328334eb46","article-title":"Risk factors and comorbidities in a community-wide sample of patients hospitalized with acute systolic or diastolic heart failure: the Worcester Heart Failure Study","volume":"21","author":"Chinali","year":"2010","journal-title":"Coron Artery Dis"},{"issue":"8","key":"10.1016\/j.hfc.2014.04.009_bib22","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jacc.2003.11.040","article-title":"Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry","volume":"43","author":"Klapholz","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2014.04.009_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0735-1097(02)02696-7","article-title":"Gender, age, and heart failure with preserved left ventricular systolic function","volume":"4","author":"Masoudi","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2014.04.009_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ahj.2012.08.014","article-title":"Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction","volume":"164","author":"Bishu","year":"2012","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2014.04.009_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","article-title":"Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)","volume":"15","author":"Yamamoto","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.hfc.2014.04.009_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.112.972794","article-title":"Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"6","author":"Shah","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.hfc.2014.04.009_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejheart.2007.12.010","article-title":"Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial","volume":"10","author":"McMurray","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.hfc.2014.04.009_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hfc.2014.04.009_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation Group","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.hfc.2014.04.009_bib33","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"issue":"9386","key":"10.1016\/j.hfc.2014.04.009_bib34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.hfc.2014.04.009_bib35","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.hfc.2014.04.009_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.hfc.2014.04.009_bib37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/eurheartj\/eht497","article-title":"Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial","volume":"35","author":"Filippatos","year":"2014","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.hfc.2014.04.009_bib38","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2013abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.hfc.2014.04.009_bib39","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"issue":"9192","key":"10.1016\/j.hfc.2014.04.009_bib40","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","article-title":"Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study","volume":"354","author":"Hansson","year":"1999","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.hfc.2014.04.009_bib41","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9426","key":"10.1016\/j.hfc.2014.04.009_bib42","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hfc.2014.04.009_bib43","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.HYP.32.6.989","article-title":"Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension","volume":"32","author":"Dahlof","year":"1998","journal-title":"Hypertension"},{"issue":"9311","key":"10.1016\/j.hfc.2014.04.009_bib44","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.hfc.2014.04.009_bib45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMoa021716","article-title":"A\u00a0comparison of outcomes with angiotensin-converting\u2013enzyme inhibitors and diuretics for hypertension in the elderly","volume":"348","author":"Wing","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.hfc.2014.04.009_bib46","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensiveand Lipid-Lowering Treatment to Prevent Heart Attack Trial","year":"2002","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.hfc.2014.04.009_bib47","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9437","key":"10.1016\/j.hfc.2014.04.009_bib48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.hfc.2014.04.009_bib49","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1008816","article-title":"Irbesartan in patients with atrial fibrillation","volume":"364","author":"ACTIVE I Investigators","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.hfc.2014.04.009_bib50","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2012.04.064","article-title":"What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?","volume":"60","author":"Campbell","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.hfc.2014.04.009_bib51","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","article-title":"Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota","volume":"115","author":"Lam","year":"2007","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.hfc.2014.04.009_bib52","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","article-title":"Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction","volume":"124","author":"Zile","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/08037050152112050","article-title":"Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study","volume":"10","author":"Devereux","year":"2001","journal-title":"Blood Press"},{"issue":"24","key":"10.1016\/j.hfc.2014.04.009_bib54","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in ecompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2014.04.009_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10741-010-9204-4","article-title":"Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship","volume":"17","author":"Caldwell","year":"2012","journal-title":"Heart Fail Rev"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib56","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0002-8703(83)90194-1","article-title":"The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model","volume":"106","author":"Naito","year":"1983","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.hfc.2014.04.009_bib57","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.amjcard.2012.12.005","article-title":"Left ventricular fibrosis in atrial fibrillation","volume":"111","author":"Shantsila","year":"2013","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.hfc.2014.04.009_bib58","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.hfc.2014.04.009_bib59","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2014.04.009_bib60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcmg.2010.10.008","article-title":"Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment","volume":"4","author":"Konstam","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"issue":"24","key":"10.1016\/j.hfc.2014.04.009_bib61","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1161\/CIRCULATIONAHA.108.824243","article-title":"Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study","volume":"119","author":"Lieb","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2014.04.009_bib62","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.110.937821","article-title":"Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study","volume":"122","author":"Cheng","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hfc.2014.04.009_bib63","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.hfc.2014.04.009_bib64","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jacc.2008.05.002","volume":"52","author":"Somers","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2014.04.009_bib65","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/heart.89.10.1152","article-title":"Effects of isolated obesity on systolic and diastolic left ventricular function","volume":"89","author":"Pascual","year":"2003","journal-title":"Heart"},{"issue":"13","key":"10.1016\/j.hfc.2014.04.009_bib66","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study","volume":"53","author":"Lam","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2014.04.009_bib67","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","article-title":"Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure","volume":"107","author":"Ezekowitz","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.hfc.2014.04.009_bib69","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCULATIONAHA.105.582577","article-title":"Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program","volume":"113","author":"O'Meara","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2014.04.009_bib70","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/eurjhf\/hfr044","article-title":"Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study","volume":"13","author":"von Haehling","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"25","key":"10.1016\/j.hfc.2014.04.009_bib71","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric\u00a0carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.hfc.2014.04.009_bib72","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.hfc.2014.04.009_bib73","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2014.04.009_bib74","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2014.04.009_bib75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.110.979203","article-title":"Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community","volume":"124","author":"Lam","year":"2011","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.hfc.2014.04.009_bib76","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.0000144474.65922.AA","article-title":"Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"110","author":"Solomon","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2014.04.009_bib77","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1388-9842(03)00052-7","article-title":"Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"5","author":"McMurray","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.hfc.2014.04.009_bib78","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"10.1016\/j.hfc.2014.04.009_bib79","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.hfc.2014.04.009_bib80","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.hfc.2014.04.009_bib81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/heartjnl-2011-301321","article-title":"Diagnosis of heart failure with preserved ejection fraction: role of clinical Doppler echocardiography","volume":"100","author":"Penicka","year":"2014","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.hfc.2014.04.009_bib82","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archinte.166.10.1081","article-title":"Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea","volume":"166","author":"Mueller","year":"2006","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.hfc.2014.04.009_bib83","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.annemergmed.2005.01.027","article-title":"Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study","volume":"45","author":"Knudsen","year":"2005","journal-title":"Ann Emerg Med"},{"issue":"7255","key":"10.1016\/j.hfc.2014.04.009_bib84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.321.7255.215","article-title":"Do patients with suspected heart failure and preserved left ventricular systolic function suffer from \u201cdiastolic heart failure\u201d or from misdiagnosis? A prospective descriptive study","volume":"321","author":"Caruana","year":"2000","journal-title":"BMJ"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713614000336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713614000336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T02:30:01Z","timestamp":1538533801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713614000336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1551713614000336"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2014.04.009","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities and Differential Diagnosis in Heart Failure with Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2014.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}